Velocity Clinical Research, Grand Island — Grand Island, Nebraska

Velocity Clinical Research, Grand Island is a clinical research site located in Grand Island, Nebraska, United States 68803.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Grand Island has participated in 14 clinical trials with 10 currently active.

Therapeutic areas: SARS-CoV-2, Obesity, COVID-19.

Sponsors: ModernaTX, Inc., Currax Pharmaceuticals, BioNTech SE.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Grand Island?

Velocity Clinical Research, Grand Island has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Grand Island conducted?

Velocity Clinical Research, Grand Island has 14 clinical trials on record, with 10 currently active. Their work covers SARS-CoV-2, Obesity, COVID-19.

Is Velocity Clinical Research, Grand Island accredited by Crixeo Health?

Yes — Velocity Clinical Research, Grand Island holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research, Grand Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.